Chinese companies MabSpace and ICT announce series B rounds

MabSpace Biosciences Co. Ltd. (Suzhou, China) and Innovative Cellular Therapeutics Co. Ltd. (Shanghai, China) raised $40 million and RMB180 million ($28.3 million), respectively, in series B rounds.

New

Read the full 276 word article

User Sign In